Trials / Completed
CompletedNCT00911677
Does APOE-e4 Predict Delirium and Cognitive Dysfunction After Surgery?
Does Apolipoprotein E Genotype Predict Delirium and Postoperative Cognitive Dysfunction?
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Ottawa Hospital Research Institute · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Patients with the APOE-ε4 genotype are at increased risk of both vascular dementia and peripheral vascular disease. Patients undergoing major vascular surgery are at particularly high risk of delirium and other, more subtle, changes in cognitive function following surgery. The hypothesis of this trial is that the APOE-ε4 genotype is associated with both delirium and postoperative cognitive dysfunction (POCD).
Conditions
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2008-03-01
- Completion
- 2009-05-01
- First posted
- 2009-06-02
- Last updated
- 2009-06-02
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00911677. Inclusion in this directory is not an endorsement.